1162 related articles for article (PubMed ID: 35135456)
21. Public Interest in Myocarditis during the SARS-CoV-2 Pandemic.
Perkins D; Wilkins R; Kerr R; Greiner B; Hartwell M
Disaster Med Public Health Prep; 2023 Mar; 17():e349. PubMed ID: 36912741
[TBL] [Abstract][Full Text] [Related]
22. The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach.
Di Paola L; Hadi-Alijanvand H; Song X; Hu G; Giuliani A
J Proteome Res; 2020 Nov; 19(11):4576-4586. PubMed ID: 32551648
[TBL] [Abstract][Full Text] [Related]
23. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
24. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
[TBL] [Abstract][Full Text] [Related]
25. An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants.
Siddique F; Abbas RZ; Mansoor MK; Alghamdi ES; Saeed M; Ayaz MM; Rahman M; Mahmood MS; Iqbal A; Manzoor M; Abbas A; Javaid A; Hussain I
Front Vet Sci; 2020; 7():586637. PubMed ID: 33521076
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in the vaccine development for the prophylaxis of SARS Covid-19.
Kumar V; Kumar S; Sharma PC
Int Immunopharmacol; 2022 Oct; 111():109175. PubMed ID: 35994853
[TBL] [Abstract][Full Text] [Related]
27. Status of COVID-19 Pandemic Before the Administration of Vaccine.
Thomas S
Methods Mol Biol; 2022; 2410():93-108. PubMed ID: 34914043
[TBL] [Abstract][Full Text] [Related]
28. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.
Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q
J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773
[TBL] [Abstract][Full Text] [Related]
29. Association Between What People Learned About COVID-19 Using Web Searches and Their Behavior Toward Public Health Guidelines: Empirical Infodemiology Study.
Akpan IJ; Aguolu OG; Kobara YM; Razavi R; Akpan AA; Shanker M
J Med Internet Res; 2021 Sep; 23(9):e28975. PubMed ID: 34280117
[TBL] [Abstract][Full Text] [Related]
30. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents.
Nandi S; Roy H; Gummadi A; Saxena AK
Curr Drug Targets; 2021; 22(17):2006-2020. PubMed ID: 33687893
[TBL] [Abstract][Full Text] [Related]
31. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
32. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
33. Importance of the SARS-CoV-2 genome and spike protein in the immunopathogenesis of COVID-19 and in the efficacy of vaccines.
Jiménez-Morales S; Pérez-Amado CJ; Montúfar-Robles I; Fragoso JM; Aranda-Uribe IS; Ramos-Puga DA; Martínez-Flores ÁE; Ramírez-Bello J
Cir Cir; 2023; 91(2):268-276. PubMed ID: 37084305
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic.
Shao Y; Wu Y; Feng Y; Xu W; Xiong F; Zhang X
Front Med; 2022 Apr; 16(2):185-195. PubMed ID: 35226300
[TBL] [Abstract][Full Text] [Related]
35. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
[TBL] [Abstract][Full Text] [Related]
36. Status of COVID-19 vaccination around South Asia.
Hayat M; Uzair M; Ali Syed R; Arshad M; Bashir S
Hum Vaccin Immunother; 2022 Dec; 18(1):2016010. PubMed ID: 35061956
[TBL] [Abstract][Full Text] [Related]
37. Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines.
Li J; Wang P; Tracey KJ; Wang H
Mol Med; 2021 May; 27(1):49. PubMed ID: 34022793
[TBL] [Abstract][Full Text] [Related]
38. A Retrospective Global Assessment of Factors Associated With COVID-19 Policies and Health Outcomes.
Choi AJ; Hean AC; Lee JK; Tran ND; Lin TK; Apollonio DE
Front Public Health; 2022; 10():843445. PubMed ID: 35615034
[TBL] [Abstract][Full Text] [Related]
39. Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2.
Huisman JS; Scire J; Angst DC; Li J; Neher RA; Maathuis MH; Bonhoeffer S; Stadler T
Elife; 2022 Aug; 11():. PubMed ID: 35938911
[TBL] [Abstract][Full Text] [Related]
40. Covid-19, an unfinished story.
Buisson Y
Presse Med; 2022 Sep; 51(3):104131. PubMed ID: 35667598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
